Edwards Lifesciences (EW) Cash & Equivalents Growth (1y) (2010 - 2026)
Edwards Lifesciences (EW) Cash & Equivalents Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.94 Bn | 194.34 Bn | 7.27 Bn | -26.57% |
| 2 | Stryker | 129.96 Bn | 126.49 Bn | 4.50 Bn | 42.78% |
| 3 | Medtronic | 120.01 Bn | 110.79 Bn | 6.41 Bn | -12.13% |
| 4 | Boston Scientific | 74.08 Bn | 73.54 Bn | 3.85 Bn | 0.94% |
| 5 | Edwards Lifesciences | 52.66 Bn | 48.40 Bn | 1.35 Bn | -11.19% |
| 6 | Dexcom | 34.63 Bn | 32.68 Bn | 830.00 Mn | -4.66% |
| 7 | GE HealthCare Technologies | 34.02 Bn | 31.91 Bn | 2.18 Bn | -44.03% |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn | 19.49% |
| 9 | Steris | 23.18 Bn | 22.69 Bn | 684.20 Mn | 72.43% |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn | -26.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -11.19% |
| Mar 31, 2026 | -22.13% |
| Dec 31, 2025 | -3.52% |
| Sep 30, 2025 | -26.95% |
| Jun 30, 2025 | 99.01% |
| Mar 31, 2025 | 156.46% |
| Dec 31, 2024 | 25,927.35% |
| Sep 30, 2024 | 160.72% |
| Jun 30, 2024 | 57.73% |
| Mar 31, 2024 | 40.36% |
| Dec 31, 2023 | -98.46% |
| Sep 30, 2023 | 13.01% |
| Jun 30, 2023 | -12.98% |
| Mar 31, 2023 | -15.37% |
| Dec 31, 2022 | -11.74% |
| Sep 30, 2022 | -17.19% |
| Jun 30, 2022 | -8.74% |
| Mar 31, 2022 | -12.20% |
| Dec 31, 2021 | -27.08% |
| Sep 30, 2021 | 47.16% |